US stock MEIP rose over 33% today, with a market value reaching 41.24 million USD
ChainCatcher news, according to market news, MEI Pharma (NASDAQ: MEIP) rose over 33% today, with a market capitalization reaching $41.2431 million.
Previously, it was reported that Titan Partners Group and crypto investment firm GSR are jointly leading a strategic transformation for the American pharmaceutical company MEI Pharma (NASDAQ: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, over $100 million in funding commitments have been made for this project. Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.






